BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32080874)

  • 1. Ensuring donor safety: is venesecting therapeutic donors to haemoglobin levels below Blood Service guidelines safe?
    Lim Z; Bentley P; Olynyk JK
    Vox Sang; 2020 May; 115(4):288-292. PubMed ID: 32080874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds.
    Eder AF; Hillyer CD; Dy BA; Notari EP; Benjamin RJ
    JAMA; 2008 May; 299(19):2279-86. PubMed ID: 18492969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of haemoglobin monitoring in apheresis plasma donors: A retrospective cohort study in Québec, Canada.
    Lewin A; Germain M; Renaud C; Robitaille N; Latour C
    Vox Sang; 2023 Dec; 118(12):1041-1045. PubMed ID: 37673797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis subjects as allogeneic blood donors: a prospective study.
    Leitman SF; Browning JN; Yau YY; Mason G; Klein HG; Conry-Cantilena C; Bolan CD
    Transfusion; 2003 Nov; 43(11):1538-44. PubMed ID: 14617312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
    Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
    Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood donation and testosterone replacement therapy.
    Chin-Yee B; Lazo-Langner A; Butler-Foster T; Hsia C; Chin-Yee I
    Transfusion; 2017 Mar; 57(3):578-581. PubMed ID: 28150363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of vasovagal reactions in Australian whole blood donors after national implementation of applied muscle tension and water loading.
    Thijsen A; Masser B; Davison TE
    Transfusion; 2020 May; 60(5):918-921. PubMed ID: 32052859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization.
    Hazegh K; Bravo MD; Kamel H; Dumont L; Kanias T
    Transfusion; 2020 May; 60(5):947-954. PubMed ID: 32176332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of haemoglobin levels in female blood donors with haemoglobin levels of 120-124 g/l at presentation.
    Gillon J; Wye A; Walker B; Phillips P
    Vox Sang; 2000; 78(4):225-30. PubMed ID: 10895095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of risk-dependent interventions on low haemoglobin deferral rates in whole blood donors.
    Baart AM; van den Hurk K; de Kort WLAM; Huis In 't Veld EMJ
    Vox Sang; 2020 Apr; 115(3):171-181. PubMed ID: 31912518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood collection failures from a blood establishment perspective.
    Radovčić MK; Ljubičić J; Očić T; Jukić I; Vuk T
    Transfus Med; 2021 Apr; 31(2):88-93. PubMed ID: 33458900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a sterile surgical skin marker to indicate the optimal vein for venepuncture in the blood donation setting.
    Bell B; O'Donovan J; Wright ST; Gemelli CN; Knight E; Hirani R
    Vox Sang; 2020 Jul; 115(5):377-387. PubMed ID: 32124456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.
    Djalali M; Neyestani TR; Bateni J; Siassi F
    Int J Vitam Nutr Res; 2006 May; 76(3):132-7. PubMed ID: 17048192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the diversity of blood donation practice across Asia: How blood collection agencies adapt donor criteria and processes to their population.
    Fung YL; Alcantara RM; Cavalli LB; Chen JW; Chen YY; Donkin R; Kupatawintu P; Kwon SY; Lee CK; Nadarajan VS; Namjil E; Bat S; Odajima T; Sachdev S; Siswishanto R; Tadsomboon S; Sharma RR; Triyono T; Tsuno NH
    Vox Sang; 2023 Dec; 118(12):1046-1060. PubMed ID: 37753662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center.
    Gribble DM; Chaffin DJ; Bryant BJ
    Immunohematology; 2009; 25(4):170-3. PubMed ID: 20406025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous sample is superior to repeated skin-prick testing in blood donor haemoglobin second-line screening.
    Bäckman S; Valkeajärvi A; Korkalainen P; Arvas M; Castrén J
    Vox Sang; 2020 Nov; 115(8):617-623. PubMed ID: 32314403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.